Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that ...
1 hour ago
0
0
Researchers have found a high level of agreement between cataract referral decisions based on smartphone images reviewed remotely and those made by ophthalmologists examining patients in person at rural eye camps.
1 hour ago
0
0
What makes the brain fall asleep? For nearly a century, scientists have looked to structures deep within the brain for the answer. In the traditional view, these regions control when we sleep and wake, while the cerebral ...
5 hours ago
0
5
More than 7,000 Ebola cases have been recorded in the Democratic Republic of Congo's worst-ever outbreak of the deadly disease, according to figures released Saturday by Congolese authorities.
6 hours ago
0
3
New blood tests that might predict Alzheimer's years before symptoms begin may sound tantalizing for people who worry about later-in-life dementia. But doctors say they aren't quite ready yet—and besides, you don't need a ...
6 hours ago
0
5
Chandler Browning always dreamed of being part of The University of Texas at Arlington's nationally recognized nursing program and pursuing her goal of becoming a certified registered nurse anesthetist. Now in her first semester ...
11 hours ago
0
5
Results from the international phase 3 SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive failure-free survival compared with MRI surveillance plus prophylactic cranial irradiation (PCI) in ...
12 hours ago
0
5
Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD-L1-positive advanced non-small cell lung cancer (NSCLC), according to a prespecified interim analysis ...
12 hours ago
0
6
Results from the randomized Phase III ARTEMIS-008 trial show that risvutatug rezetecan (Ris-Rez), a B7-H3-directed antibody-drug conjugate, significantly improved overall survival compared with topotecan in patients with ...
12 hours ago
0
4
Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab alone as first-line treatment for patients with metastatic ...
12 hours ago
0
4
